UBS OCONNOR LLC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 196 filers reported holding VIKING THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$641,008
-5.6%
57,905
+38.2%
0.02%
-23.8%
Q2 2023$679,280
-37.8%
41,905
-36.1%
0.02%
-38.2%
Q1 2023$1,092,373
-99.8%
65,608
-73.4%
0.03%
+161.5%
Q3 2022$672,000,000
-14.6%
247,000
+140.2%
0.01%
-53.6%
Q4 2018$787,000,000
-52.4%
102,842
+8.3%
0.03%
-26.3%
Q3 2018$1,655,000,00095,0000.04%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders